We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Panel Supports Extending Gardasil Label to Anal Cancer
FDA Panel Supports Extending Gardasil Label to Anal Cancer
November 24, 2010
An FDA advisory panel has supported Merck’s Gardasil vaccine to prevent anal cancer and anal intraepithelial neoplasia (AIN) in both males and females age 9 to 26.